GalNAc-siTAZ improves hepatic inflammation, fibrosis and liver damage in models of NASH Oct. 15, 2019
Auris reports phase Ib interim data on AM-201 for antipsychotic-induced weight gain and somnolence Oct. 14, 2019
Eyevensys provides initial data from phase I/II study of EYS-606 for noninfectious uveitis Oct. 14, 2019
RSS